Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Molecular Cytogenetics Market
Molecular Cytogenetics Market


Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular techniques. Molecular Cytogenetics mainly defines a huge set of the methods that function either with the whole genome or with specific targeted DNA sequences. Topical areas consist Structural and functional arrangement of chromosome and nucleus.

Competitive Landscape:

Key players involved in the growth of global Molecular Cytogenetics Market are Oxford Gene Technology, F.Hoffmann-La Roche Ltd., Abbott Laboratories, Agilent Technologies, Inc., Quest Diagnostics, PerkinElmer Inc, Bio-Rad Laboratories, Inc., Illumina, Inc., and Thermo Fisher Scientific.

Market Key Drivers:


Increasing number of cancer cases and genetic disorders is expected to propel the growth of the global Molecular Cytogenetics Market. For instance, as per WHO, around 20 million people suffer from cancer across the globe in 2023.

The technological developments in molecular cytogenetics is anticipated to boost the growth of global Molecular Cytogenetics Market. For instance, in October 2022, Thermo Fisher Scientific enhanced its Applied Biosystems Chromosome Analysis Suite software by a partnership with Genoox.

Covid-19 Impact Analysis:

The Covid-19 outbreak has significantly affected the growth of the global Molecular Cytogenetics Market. In the pandemic the modification in genetic substances in affected people was detected with the help of cytogenetics. For example, as per Nature journal’s article, genetic factors impelling COVID-19 susceptibility and severity presented new biological insights into disease etiology and detect molecular targets for development of treatment or medication repurposing.

Key Takeaways:

The global Molecular Cytogenetics Market is anticipated to exhibit a CAGR of 24.5 % during the forecast period owing to the rising approvals and product launches. For instance, in May 2022 Pfizer offered a medical approval which assists the global healthcare community’s independent enterprises to increase patient outcomes in fields of unmet clinical necessities that are allied with Pfizer’s medical or scientific plans. 

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in global Molecular Cytogenetics Market due to increasing mergers and acquisitions, increasing partnerships and collaborations and increasing prevalence of cancer. For instance, as per the Canadian Cancer Society 2022 update, around 233,900 people in Canada were diagnosed with cancer.

Comments

Post a Comment

Popular posts from this blog

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C...
Read more